Calidad de la evidencia 4.75/5
Puntuación de revisión en ocho dimensiones según la rúbrica de calidad . Cada dimensión puntuada de 1 a 5.
- D1 Anclaje en las fuentes
- 4/5
- D2 Autoridad de las fuentes
- 5/5
- D3 Aritmética
- 5/5
- D4 Incertidumbre
- 4/5
- D5 Alcance
- 5/5
- D6 Prosa
- 5/5
- D7 Honestidad sobre la percepción
- 5/5
- D8 Completitud de las advertencias
- 5/5
Cómo varía el riesgo
La cifra principal promedia situaciones muy diferentes. Así es como varía la probabilidad según el escenario o el contexto:
—
At 200–400 mg aspartame/day, exposure is 7–14% of the ADI. No regulatory body identifies measurable cancer risk at this level.
—
At 800+ mg/day, still below half the ADI for a 70 kg adult. No cohort data shows dose-response at this range; Debras et al. grouped all above-median consumers together.
—
Saccharin was delisted as a carcinogen by the NTP in 2000 after the rat-bladder mechanism was shown to be species-specific. FDA, EFSA, and JECFA all consider saccharin safe at approved levels.
—
Sucralose has not been classified by IARC. FDA approved it in 1998; no large cohort study has linked it to cancer in humans at dietary exposure levels.
La longitud y el tono de la barra clasifican estos escenarios entre sí, no frente a otros riesgos. Las probabilidades exactas se muestran junto a cada uno.
En julio de 2023, la IARC clasificó el aspartamo como Grupo 2B — “posiblemente carcinógeno para los humanos” — y los titulares se escribieron solos. Lo que la mayoría de la cobertura omitió: el mismo día, el JECFA reafirmó la ingesta diaria aceptable existente de 40 mg/kg/día, sin encontrar razón para cambiarla. Un adulto de 70 kg necesitaría aproximadamente 14 latas de refresco dietético al día para alcanzar ese umbral. La única cohorte que impulsó la clasificación, Debras et al. 2022, informó una razón de riesgo de 1.13 para los consumidores por encima de la mediana frente a los no consumidores — un efecto modesto cuyo límite inferior de confianza apenas excluye 1.0, de un estudio observacional con datos dietéticos autoinformados y sin replicación. La FDA, la EFSA y el JECFA mantienen que el aspartamo es seguro en los niveles de consumo actuales.
El patrón es familiar. La sacarina fue prohibida en Canadá en 1977 y casi prohibida en EE. UU. después de que estudios encontraran tumores de vejiga en ratas. Dos décadas después, el mecanismo resultó ser específico de la especie: las ratas macho producen una proteína que se une a los metabolitos de la sacarina en la orina e irrita el epitelio de la vejiga. Los humanos no producen esta proteína. El NTP eliminó la sacarina como carcinógeno en 2000. La categoría Grupo 2B de la IARC contiene más de 300 agentes — incluyendo extracto de hoja entera de aloe vera, vegetales encurtidos y la exposición ocupacional como bombero — y señala “evidencia limitada, digna de observación”, no “esto causa cáncer en la dosis de su mesa de desayuno”.
Ningún organismo regulador en el mundo ha cuantificado una probabilidad de cáncer atribuible al consumo de edulcorantes artificiales en los niveles aprobados. La brecha entre la percepción pública y el consenso regulatorio es marcada: los consumidores evitan los refrescos dietéticos por miedo al cáncer, mientras que tres agencias independientes (FDA, EFSA, JECFA), revisando la misma evidencia, concluyen que el riesgo atribuible no es distinguible de cero con una ingesta normal. Eso no significa que futuras investigaciones no puedan cambiar el panorama — significa que la evidencia actual no respalda un número, y publicar uno sería una fabricación disfrazada de cuantificación.
Datos curiosos relacionados
No hay estimación fiable que vincule los edulcorantes aprobados con el cáncer a una ingesta normal. Las revisiones regulatorias y los grandes estudios de cohortes no han establecido un efecto causal, así que no publicamos ninguna cifra en lugar de inventarla.
Registro de evidencia
Cada número a continuación es lo que reportó cada fuente, con la cita textual en la que nos basamos y cómo llegamos a nuestra cifra. Haz clic en cualquier enlace para verificarlo directamente.
1/6 fuentes verificadas de forma independiente palabra por palabra frente a la fuente citada
-
[1] International Agency for Research on Cancer (WHO) — Summary of Results — IARC Monographs Volume 134: Aspartame
Summary of Results — IARC Monographs Volume 134: Aspartame- Estadística
Aspartame classified as Group 2B (possibly carcinogenic to humans) based on limited evidence in humans and less than sufficient evidence in experimental animals- Extracto
“"The working group classified aspartame as possibly carcinogenic to humans (Group 2B) based on limited evidence for cancer in humans (for hepatocellular carcinoma," ”
- Datos de la fuente de
- 2023-07-14
- Accedido
- 2026-04-18 · copia archivada
- Cálculo
- IARC's Group 2B is the third of four levels and indicates limited evidence in humans plus less than sufficient evidence in animals — it is a hazard-identification classification, not a risk quantification. Over 300 agents are classified 2B, including aloe vera extract, pickled vegetables, and radio-frequency electromagnetic fields. The classification does not estimate the probability of cancer at any exposure level, and IARC explicitly noted that the evidence came primarily from a single cohort (NutriNet-Santé) with effect sizes that were borderline after correction for multiple comparisons.
-
[2] World Health Organization / Joint FAO/WHO Expert Committee on Food Additives (JECFA) — Aspartame hazard and risk assessment results released Verificado
Aspartame hazard and risk assessment results released- Estadística
JECFA reaffirmed the existing ADI of 0–40 mg/kg body weight/day, finding no convincing evidence of harm at current consumption levels- Extracto
“"JECFA concluded that the data evaluated indicated no sufficient reason to change the previously established acceptable daily intake (ADI) of 0-40 mg/kg body weight for aspartame." ”
- Datos de la fuente de
- 2023-07-14
- Accedido
- 2026-04-18 · copia archivada
- Verificación
- Extracto recuperado de forma independiente y confirmado palabra por palabra frente a la fuente citada durante nuestra auditoría de fundamentación.
- Cálculo
- JECFA's evaluation was released simultaneously with IARC's classification. For a 70 kg adult, the ADI of 40 mg/kg/day equals 2,800 mg/day. A 355 ml (12 oz) can of diet soda contains roughly 200 mg of aspartame. Reaching the ADI would require consuming approximately 14 cans per day — a level well beyond typical consumption of 1–2 cans. JECFA and IARC used different frameworks: IARC identifies hazard (can it cause cancer under any conditions?), JECFA assesses risk (does it cause cancer at actual human exposure levels?). The divergence is methodological, not contradictory.
-
[3] PLoS Medicine / Debras et al. — Artificial sweeteners and cancer risk: Results from the NutriNet-Santé population-based cohort study
Artificial sweeteners and cancer risk: Results from the NutriNet-Santé population-based cohort study- Estadística
Higher consumers of artificial sweeteners (above median) had HR 1.13 (95% CI 1.03–1.25) for overall cancer risk vs non-consumers- Extracto
“"Compared to non-consumers, higher consumers of total artificial sweeteners (i.e., above the median exposure in consumers) had higher risk of overall cancer (n = 3,358 cases, hazard ratio [HR] = 1.13 [95% CI 1.03 to 1.25], P-trend = 0.002)." ”
- Datos de la fuente de
- 2022-03-24
- Accedido
- 2026-04-18 · copia archivada
- Cálculo
- Debras et al. followed 102,865 adults from the French NutriNet-Santé cohort (2009–2021). The reported HR of 1.13 is modest and the lower confidence bound (1.03) barely excludes 1.0. The study is observational with self-reported dietary intake, subject to residual confounding (diet-soda consumers may differ systematically from non-consumers). This is the primary human study cited by IARC for the 2B classification. No prior large cohort has replicated the finding. The authors themselves note the result warrants replication and does not establish causation.
-
[4] U.S. Food and Drug Administration — Aspartame and Other Sweeteners in Food
Aspartame and Other Sweeteners in Food- Estadística
FDA does not agree with IARC's conclusion that aspartame is a possible carcinogen; FDA considers aspartame safe at current approved levels- Extracto
“"FDA disagrees with IARC’s conclusion that these studies support classifying aspartame as a possible carcinogen to humans. … FDA scientists do not have safety concerns when aspartame is used under the approved conditions." ”
- Datos de la fuente de
- 2023-07-14
- Accedido
- 2026-04-18 · copia archivada
- Cálculo
- FDA's position reflects its own review of the same evidence considered by IARC, including the Ramazzini Institute animal studies (which FDA found methodologically flawed) and the NutriNet-Santé cohort. FDA has approved aspartame since 1981 and has reviewed its safety multiple times. The FDA ADI is 50 mg/kg/day — higher than JECFA's 40 mg/kg/day — reflecting an independent risk assessment reaching a similar conclusion of safety at normal consumption.
-
[5] European Food Safety Authority (EFSA) — Scientific Opinion on the re-evaluation of aspartame (E 951) as a food additive
Scientific Opinion on the re-evaluation of aspartame (E 951) as a food additive- Estadística
EFSA concluded aspartame and its breakdown products are safe for general population at current exposure levels, setting ADI at 40 mg/kg/day- Extracto
“"The Panel concluded that aspartame was not of safety concern at the current aspartame exposure estimates or at the ADI of 40 mg/kg bw/day." ”
- Datos de la fuente de
- 2013-12-10
- Accedido
- 2026-04-18 · copia archivada
- Cálculo
- EFSA's 2013 opinion was the most comprehensive regulatory review of aspartame to date, examining over 600 datasets. EFSA found no evidence of genotoxicity or carcinogenicity at doses below the ADI. Actual European population exposure was estimated at 2.8–10 mg/kg/day in high consumers — well below the ADI. This review predates the Debras et al. 2022 study but remains the benchmark regulatory assessment, and EFSA has not revised it following the IARC 2B classification.
-
[6] Wikipedia — Saccharin
Saccharin- Estadística
In 1977 the FDA attempted to completely ban saccharin after rat studies showed bladder tumors, but the ban was blocked by public opposition; Canada separately banned it as a food additive around the same time before later lifting that ban- Extracto
“"In 1977, the FDA made an attempt to completely ban the substance, following studies showing that the substance caused bladder cancer in rats. The attempted ban was unsuccessful due to public opposition that was encouraged by industry advertisements." ”
- Datos de la fuente de
- 2026-06-01
- Accedido
- 2026-07-03 · copia archivada
- Cálculo
- Supports the body's historical analogy between the 2023 IARC aspartame classification and the earlier saccharin cancer scare. Congress's Saccharin Study and Labeling Act of 1977 imposed an 18-month moratorium on the FDA's proposed ban and substituted a warning-label requirement instead; the FDA formally withdrew its 1977 ban proposal in 1991. Canada separately removed saccharin from sale as a food additive around 1977 and later lifted that restriction. Neither figure changes this entry's headline no_reliable_estimate status for sweeteners generally — this is background context for the saccharin-specific analogy in the body text, not a claim about artificial sweeteners currently on the market.